Abstract
Phorbol, the unesterified parent alcohol of the skin promoter TPA, was administered i.p., twice weekly, throughout the lifetime of mice of 7 inbred strains: males and females of AKR/J, C3Heb and BALB/c, and females of SJL/J, DBA/2, SWR and C57BL. A striking difference in strain response was observed, with a pronounced leukaemogenic effect in SWR, a signficiant shortening of the latent period for spontaneous reticulum cell sarcomas (RCNB) in SJL/J, and no demonstrable effect in the other strains. When mice of 3 of the above-mentioned strains (SWR, SJL/J and AKR/J) were thymectomized prior to the beginning of phorbol treatment, different patterns of response were again observed. Thymectomy did not influence the leukaemia incidence in SWR mice, slightly inhibited RCNB development in SJL/J mice and converted phorbol into a leukaemogenic agent for AKR/J mice.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Armuth V., Berenblum I. Phorbol as a possible systemic promoting agent for skin carcinogenesis. Z Krebsforsch Klin Onkol Cancer Res Clin Oncol. 1976 Jan 2;85(1):79–82. doi: 10.1007/BF00308132. [DOI] [PubMed] [Google Scholar]
- Armuth V., Berenblum I. Promotion of mammary carcinogenesis and leukemogenic action by phorbol in virgin female Wistar rats. Cancer Res. 1974 Oct;34(10):2704–2707. [PubMed] [Google Scholar]
- Armuth V., Berenblum I. Systemic promoting action of phorbol in liver and lung carcinogenesis in AKR mice. Cancer Res. 1972 Oct;32(10):2259–2262. [PubMed] [Google Scholar]
- Baird W. M., Boutwell R. K. Tumor-promoting activity of phorbol and four diesters of phorbol in mouse skin. Cancer Res. 1971 Aug;31(8):1074–1079. [PubMed] [Google Scholar]
- Berenblum I., Lonai V. The leukemogenic action of phorbol. Cancer Res. 1970 Nov;30(11):2744–2748. [PubMed] [Google Scholar]
- DOELL R. G., CARNES W. H. Urethan induction of thymic lymphoma in C57bl mice. Nature. 1962 May 12;194:588–589. doi: 10.1038/194588a0. [DOI] [PubMed] [Google Scholar]
- DUNN T. B. Normal and pathologic anatomy of the reticular tissue in laboratory mice, with a classification and discussion of neoplasms. J Natl Cancer Inst. 1954 Jun;14(6):1281–1433. [PubMed] [Google Scholar]
- Dexter T. M., Schofield R., Lajtha L. G., Moore M. Studies on the mechanisms of chemical leukaemogenesis. Br J Cancer. 1974 Oct;30(4):325–331. doi: 10.1038/bjc.1974.200. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gericke D., Kovac W., Hecker E. On a possible cocarcinogenic and immunosuppressive activity of phorbol in AKR-mice. Z Krebsforsch Klin Onkol Cancer Res Clin Oncol. 1974;82(3):183–189. doi: 10.1007/BF00304057. [DOI] [PubMed] [Google Scholar]
- Gillette R. W., Fox A. The effect of T lymphocyte deficiency on tumor induction and growth. Cell Immunol. 1975 Oct;19(2):328–335. doi: 10.1016/0008-8749(75)90214-2. [DOI] [PubMed] [Google Scholar]
- Greenberg R. S., Zatz M. M. Spontaneous AKR lymphoma with T and B-cell characteristics. Nature. 1975 Sep 25;257(5524):314–316. doi: 10.1038/257314a0. [DOI] [PubMed] [Google Scholar]
- Haran-Chera N., Peled A. Thymus and bone marrow derived lymphatic leukaemia in mice. Nature. 1973 Feb 9;241(5389):396–398. doi: 10.1038/241396a0. [DOI] [PubMed] [Google Scholar]
- Kouri R. E., Ratrie H., Whitmire C. E. Evidence of a genetic relationship between susceptibility to 3-methyl-cholanthrene-induced subcutaneous tumors and inducibility of aryl hydrocarbon hydroxylase. J Natl Cancer Inst. 1973 Jul;51(1):197–200. doi: 10.1093/jnci/51.1.197. [DOI] [PubMed] [Google Scholar]
- Lamon E. W., Wigzell H., Andersson B., Klein E. Antitumour activity in vitro dependent on immune B lymphocytes. Nat New Biol. 1973 Aug 15;244(137):209–211. doi: 10.1038/newbio244209a0. [DOI] [PubMed] [Google Scholar]
- Van Duuren B. L. Tumor-promoting agents in two-stage carcinogenesis. Prog Exp Tumor Res. 1969;11:31–68. doi: 10.1159/000391388. [DOI] [PubMed] [Google Scholar]